The missense variant NM_001369369.1(FOXN1):c.880G>A (p.Val294Ile) is located within the DNA binding forkhead domain (amino acids 270-367) at amino acid position 294, and thus meets PM1. This variant occurs at the same codon as Val294Leu which has been classified as Likely Pathogenic by the SCID VCEP (PM5_supporting). The variant has a REVEL score of 0.731 which is above the SCID VCEP specified threshold of ≥0.644 to support a deleterious effect of the variant (PP3). A luciferase reporter construct was cotransfected into heterologous cells together with an expression vector containing FOXN1. The Val294Ile variant had 18% luciferase activity compared to WT which is below the <50% threshold for PS3_moderate(PMID: 37419334). The highest MAF in gnomAD v2.1.1 is 0.000008790 (1/113770 alleles) in the European (non-Finnish) population. This is below the SCID VCEP specified threshold of <0.00002412 (PM2_supporting). Patient P2 (PMID: 30903456) is homozygous for this variant (PM3_supporting), and was diagnosed with T-B+NK+ SCID with absent CD3+ cells and absent TRECs, a poor proliferative response to PHA, athymia, alopecia totalis, and nail dystrophy. The patient was sequenced using a NGS panel of 18 common SCID-related genes and Sanger sequencing for FOXN1. Together this is a highly specific phenotype for FOXN1-related T-cell immunodeficiency, congenital alopecia, and nail dystrophy (PP4). Siblings P1 and P2 (PMID: 30903456) are both affected with T-B+NK+ SCID and homozygous for this variant (PP1), the parents are both heterozygous and do not have any immunodeficiency but have decreased T cell counts and reduced TREC levels compared to age-matched controls. In summary this variant meets criteria to be classified as likely pathogenic for semidominant T-cell immunodeficiency, congenital alopecia, and nail dystrophy due to FOXN1 deficiency based on the ACMG/AMP criteria applied: PM1, PM5_supporting, PP3, PS3_moderate, PM2_supporting, PM3_supporting, PP1, and PP4, as specified by the ClinGen SCID VCEP FOXN1 subgroup.